InvestorsHub Logo
Followers 54
Posts 10361
Boards Moderated 0
Alias Born 05/09/2015

Re: None

Thursday, 03/02/2017 2:15:52 PM

Thursday, March 02, 2017 2:15:52 PM

Post# of 9818
From the OBMP article: "OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP), a biopharmaceutical company making strides in the $7.1 billion prostate cancer treatment space, has been one of our clear favorites. We started casing the story back in mid-December, when it was trading around $0.15/share. The message was simple then, and its simple now: The market is still not pricing in any of the company’s probabilistic value as a biotech with advanced progress on the R&D side in a huge end market."



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News